KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $75.8 million.

  • West Pharmaceutical Services' Other Non-Current Assets rose 937.95% to $75.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.8 million, marking a year-over-year increase of 937.95%. This contributed to the annual value of $74.3 million for FY2024, which is 24882.63% up from last year.
  • Latest data reveals that West Pharmaceutical Services reported Other Non-Current Assets of $75.8 million as of Q3 2025, which was up 937.95% from $70.5 million recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Other Non-Current Assets ranged from a high of $75.8 million in Q3 2025 and a low of $19.0 million during Q1 2024
  • In the last 5 years, West Pharmaceutical Services' Other Non-Current Assets had a median value of $40.3 million in 2023 and averaged $45.7 million.
  • As far as peak fluctuations go, West Pharmaceutical Services' Other Non-Current Assets crashed by 4822.89% in 2024, and later skyrocketed by 26947.37% in 2025.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Other Non-Current Assets stood at $39.2 million in 2021, then dropped by 2.04% to $38.4 million in 2022, then crashed by 44.53% to $21.3 million in 2023, then surged by 248.83% to $74.3 million in 2024, then rose by 2.02% to $75.8 million in 2025.
  • Its Other Non-Current Assets stands at $75.8 million for Q3 2025, versus $70.5 million for Q2 2025 and $70.2 million for Q1 2025.